ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose
Statin Use Not Linked to COVID-19 Mortality in Hospitalized Patients
Statin use associated with increased relative risk for severe disease among hospitalized patients with COVID-19
Biden Administration Presses Schools to Provide COVID-19 Shots to Children
White House also teaming up with AAP to have local physicians provide schools with science-based info about the vaccines
Pfizer Set to Ask FDA to Approve Booster for Those 18 and Older
Approval would fulfill the Biden administration's plan to provide boosters for all adults and could increase booster rates at a critical point in the pandemic
Mortality Up for Non-Hispanic American Indians/Alaska Natives
Higher age-specific death rates at most ages, especially younger ages; higher mortality seen for most leading causes of death
Adults With IBD Show Antibody Response to mRNA COVID-19 Vaccine
After mRNA COVID-19 vaccination, 99 percent of patients with IBD had detectable antibodies regardless of immunocompromising therapies
Higher Dose of Steroid Does Not Improve Outcomes in Severe COVID-19
Number of days alive without life support at day 28 did not differ with dexamethasone 12 mg versus 6 mg in those with severe hypoxemia
Clinically Active IBD Linked to Adverse COVID-19 Outcomes
Measure indicating greater activity of IBD independently linked to ICU/ventilation/death and hospitalization among patients 50 years or younger
Cognitive Dysfunction Fairly Common After COVID-19 Infection
Impairments in executive functioning, processing speed, category fluency, memory encoding, and recall seen months after hospitalization
Fluvoxamine Cuts Hospitalizations in High-Risk COVID-19 Outpatients
Rate of high-risk COVID-19 outpatients needing prolonged emergency care or transfer to tertiary hospital lower with fluvoxamine versus placebo
